4 results for "Edward Fielder"
Showing 1–4 · 0.39 seconds · RSS
-
Journal Article
Senolytics and senostatics as adjuvant tumour therapy
Cell senescence is a driver of ageing, frailty, age-associated disease and functional decline. In oncology, tumour cell senescence may contribute to the effect of adjuvant therapies, as it blocks tumour growth. However, this is frequently incomplete, and tumour cells that recover from senescence…
-
Journal Article
Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice
Cancer survivors suffer from progressive frailty, multimorbidity, and premature morbidity. We hypothesise that therapy-induced senescence and senescence progression via bystander effects are significant causes of this premature ageing phenotype. Accordingly, the study addresses the question whether…
-
Journal Article Full text
Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice
Abstract Cellular senescence is characterized by an irreversible cell cycle arrest and a pro‐inflammatory senescence‐associated secretory phenotype (SASP), which is a major contributor to aging and age‐related diseases. Clearance of senescent cells has been shown to improve brain function in mouse…
-
Journal Article
Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk
Autophagy declines with age, yet it is unclear if restoration of autophagy extends lifespan. Here, the authors demonstrate in murine models that the inhibition of Atg5 induces ageing phenotypes and reduces lifespan, whilst autophagy restoration partially reverses these phenotypes with accelerated…